argus

Ipca Laboratories Ltd.

NSE: IPCALABINE571A0103849,887 Cr

Timeline

Time (IST)TypeMEventSrc
17 Aug, 12:07 pmIPCA Laboratories Limited has informed the Exchange about Transcriptnse
17 Aug, 11:59 amIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
14 Aug, 05:26 pmIPCA Laboratories Limited has informed the Exchange about Link of Recordingnse
14 Aug, 05:18 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Aug, 01:40 pmIpca Laboratories Ltd - 524494 - Standalone And Consolidated Unaudited Financial Results For Q1FY27bse
13 Aug, 01:35 pmIPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
13 Aug, 01:33 pmIpca Laboratories Ltd - 524494 - Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For Q1FY27bse
28 Jul, 09:24 amIpca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Financial Results For 1St Quarter Ended 30Th June, 2026bse
17 Jul, 03:26 pmIPCA Laboratories Limited has informed the Exchange regarding ''.Intimation to non-email cases regarding weblink of Annual Report'nse
14 Jul, 04:05 pmIPCA Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Aug-2026.nse
14 Jul, 11:03 amIPCA Laboratories Limited has informed the Exchange regarding 'Business Responsibility and & Sustainability Report'.nse
14 Jul, 10:11 amIpca Laboratories Ltd - 524494 - Reg. 34 (1) Annual Report.bse
07 Jul, 12:13 pmIPCA Laboratories Limited has informed the Exchange about Credit Ratingnse
07 Jul, 12:03 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
26 Jun, 01:16 pmIPCA Laboratories Limited has informed the Exchange about Amalgamation/Mergernse
26 Jun, 01:15 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Scheme of Arrangementbse
26 Jun, 01:12 pmIPCA Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 26, 2026.nse
12 Jun, 05:31 pmm_and_a2Ipca Laboratories announced a licensing agreement with BRL to access BRL's proprietary high-concentration subcutaneous biologics delivery platform for developing and commercializing multiple monoclonal antibody products for oncology and inflammatory diseases.nse
04 Jun, 01:48 pmIPCA Laboratories Limited has informed the Exchange about Transcriptnse
04 Jun, 01:44 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
01 Jun, 05:18 pmIPCA Laboratories Limited has informed the Exchange about Link of Recordingnse
01 Jun, 05:14 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
01 Jun, 09:43 amIPCA Laboratories Limited has informed the Exchange regarding 'Revised Link for q4FY26 Conference Call to be held today'.nse
29 May, 02:06 pmIPCA Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 6 per equity share.nse
29 May, 02:03 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Dividend Updatesbse
29 May, 02:01 pmIPCA Laboratories Limited has informed the Exchange regarding re-appointment of Mr Mr. Prashant Godha as Executive Director of the company w.e.f. August 16, 2026.nse
29 May, 01:59 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Change in Managementbse
29 May, 01:55 pmIpca Laboratories Ltd - 524494 - Standalone And Consolidated Results Q4FY26bse
29 May, 01:51 pmIPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
29 May, 01:49 pmIpca Laboratories Ltd - 524494 - Board Meeting Outcome for Outcome Of Board Meetingbse
27 May, 02:49 pmIpca Laboratories Ltd - 524494 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
04 May, 04:30 pmIpca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividendbse
10 Apr, 05:19 pmKaygee Investments Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
18 Feb, 01:40 pmIPCA Laboratories Limited has informed the Exchange about Transcriptnse
18 Feb, 01:38 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
16 Feb, 05:29 pmIPCA Laboratories Limited has informed the Exchange about Link of Recordingnse
16 Feb, 05:26 pmIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Feb, 01:41 pmIpca Laboratories Ltd - 524494 - Standalone And Consolidated Financial Results For Q3FY26bse
13 Feb, 01:38 pmIPCA Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
13 Feb, 01:36 pmIpca Laboratories Ltd - 524494 - Board Meeting Outcome for Standalone And Consolidated Financial Results For Q3FY26bse
09 Feb, 05:14 pmIPCA Laboratories Limited has informed the Exchange about "Commencement of commercial production at Company's new manufacturing unit situated Village Hingani,District - Wardha"nse
07 Feb, 12:46 pmIpca Laboratories Ltd - 524494 - Disclosure pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015bse
07 Feb, 11:41 amIPCA Laboratories Limited has informed the Exchange about General Updates "nse
22 Jan, 11:22 amIpca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December, 2025bse
22 Jan, 11:21 amIpca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December, 2025bse
21 Jan, 03:48 pmIPCA Laboratories Limited has informed the Exchange regarding 'Relodgement of transfer requests'.nse
21 Jan, 03:41 pmIpca Laboratories Ltd - 524494 - Re-Lodgement Of Transfer Request Report - November 2025 And December 2025bse
13 Jan, 10:49 amIPCA Laboratories Limited has informed the Exchange regarding ''Sale of 100% equity shares of wholly owned step-down subsidiary and Updation of Registered Office Address"nse
13 Jan, 10:44 amIpca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Change in Registered Office Addressbse
13 Jan, 10:42 amIPCA Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on January 13, 2026.nse